Skip to main content




Denali is committed to partnering with patients to discover and develop new, effective medicines for neurodegenerative diseases.

We are currently in the early stages of drug discovery and development and not actively enrolling patients in clinical trials at this time. If you are interested in receiving information from Denali about future clinical trials and research, please provide your information below.









© 2017 Denali Therapeutics Inc. | 151 Oyster Point Blvd – South San Francisco, CA 94080 |

Privacy Policy | Terms of Use